MV Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36.3K | Buy |
69
+2
| +3% | +$1.12K | ﹤0.01% | 375 |
|
|
2026
Q1 | $37.6K | Sell |
67
-1
| -1% | -$641 | ﹤0.01% | 362 |
|
|
2025
Q4 | $46K | Buy |
68
+2
| +3% | +$1.36K | ﹤0.01% | 323 |
|
|
2025
Q3 | $42.2K | Hold |
66
| – | – | ﹤0.01% | 333 |
|
|
2025
Q2 | $35.4K | Sell |
66
-1
| -1% | -$478 | ﹤0.01% | 352 |
|
|
2025
Q1 | $28.1K | Buy |
67
+2
| +3% | +$868 | ﹤0.01% | 382 |
|
|
2024
Q4 | $26.9K | Buy |
65
+6
| +10% | +$2.63K | ﹤0.01% | 374 |
|
|
2024
Q3 | $29.8K | Sell |
59
-3
| -5% | -$1.46K | ﹤0.01% | 374 |
|
|
2024
Q2 | $30.2K | Buy |
62
+6
| +11% | +$3.01K | ﹤0.01% | 354 |
|
|
2024
Q1 | $30.2K | Buy |
56
+1
| +2% | +$546 | ﹤0.01% | 360 |
|
|
2023
Q4 | $30.5K | Buy |
55
+1
| +2% | +$469 | ﹤0.01% | 358 |
|
|
2023
Q3 | $23.6K | Sell |
54
-1
| -2% | -$499 | ﹤0.01% | 366 |
|
|
2023
Q2 | $27.6K | Buy |
55
+2
| +4% | +$958 | ﹤0.01% | 365 |
|
|
2023
Q1 | $26.5K | Buy |
53
+10
| +23% | +$4.79K | ﹤0.01% | 357 |
|
|
2022
Q4 | $17.5K | Sell |
43
-15
| -26% | -$5.82K | ﹤0.01% | 365 |
|
|
2022
Q3 | $19K | Buy |
58
+20
| +53% | +$7.35K | ﹤0.01% | 340 |
|
|
2022
Q2 | $13K | Buy |
38
+29
| +322% | +$11.8K | ﹤0.01% | 386 |
|
|
2022
Q1 | $5K | Sell |
9
-24
| -73% | -$12.6K | ﹤0.01% | 598 |
|
|
2021
Q4 | $22K | Buy |
33
+10
| +43% | +$6.28K | ﹤0.01% | 302 |
|
|
2021
Q3 | $14K | Buy |
23
+6
| +35% | +$4.03K | ﹤0.01% | 370 |
|
|
2021
Q2 | $11K | Buy |
17
+14
| +467% | +$7.73K | ﹤0.01% | 349 |
|
|
2021
Q1 | $1K | Buy |
+3
| New | +$1.5K | ﹤0.01% | 382 |
|
|
2019
Q3 | – | Sell |
-6
| Closed | -$2K | – | 396 |
|
|
2019
Q2 | $2K | Sell |
6
-18
| -75% | -$4.43K | ﹤0.01% | 324 |
|
|
2019
Q1 | $5K | Hold |
24
| – | – | ﹤0.01% | 287 |
|
|
2018
Q4 | $4K | Hold |
24
| – | – | ﹤0.01% | 276 |
|
|
2018
Q3 | $6K | Buy |
24
+6
| +33% | +$1.46K | ﹤0.01% | 285 |
|
|
2018
Q2 | $4K | Sell |
18
-21
| -54% | -$4.33K | ﹤0.01% | 326 |
|
|
2018
Q1 | $7K | Sell |
39
-29
| -43% | -$5.35K | ﹤0.01% | 272 |
|
|
2017
Q4 | $11K | Sell |
68
-9
| -12% | -$1.42K | ﹤0.01% | 245 |
|
|
2017
Q3 | $12K | Hold |
77
| – | – | ﹤0.01% | 237 |
|
|
2017
Q2 | $12K | Buy |
77
+39
| +103% | +$6.33K | ﹤0.01% | 235 |
|
|
2017
Q1 | $6K | Buy |
38
+25
| +192% | +$3.45K | ﹤0.01% | 274 |
|
|
2016
Q4 | $2K | Buy |
13
+4
| +44% | +$456 | ﹤0.01% | 334 |
|
|
2016
Q3 | $1K | Buy |
+9
| New | +$949 | ﹤0.01% | 340 |
|
Other funds holding IDXX
MV Capital Management's IDXX Position: Q2 2026 in Review
MV Capital Management increased its Idexx Laboratories (IDXX) stake by 3% in Q2 2026, buying an estimated $1.12K and bringing the position to 69 shares worth $36.3K. The position accounts for ﹤0.01% of the portfolio, ranked #375.
MV Capital Management first reported a position in IDXX in Q3 2016 and has held it in 34 quarters since. The position peaked at $46K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- MV Capital Management held 69 shares of Idexx Laboratories worth $36.3K as of Q2 2026.
- MV Capital Management bought 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
- Idexx Laboratories made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #375 holding.
- MV Capital Management first reported a position in Idexx Laboratories in Q3 2016 and has held it in 34 quarters since.
- MV Capital Management's Idexx Laboratories position peaked at $46K in Q4 2025.
- 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.